Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2020-01-16 and last amended on 2019-12-16. Previous Versions

PART GControlled Drugs (continued)

DIVISION 6General (continued)

Marginal note:Identification or analysis of controlled drug

  •  (1) Despite anything in this Part, a person may, for the purpose of identification or analysis of a controlled drug, provide or deliver the drug to

    • (a) a practitioner of medicine; or

    • (b) an agent or mandatary of a practitioner of medicine, if the agent or mandatary is exempted under section 56 of the Act with respect to the possession of that drug for that purpose.

  • Marginal note:Agent or mandatary of practitioner of medicine

    (2) An agent or mandatary of a practitioner of medicine who receives the controlled drug must immediately provide or deliver it to

    • (a) the practitioner; or

    • (b) the Minister.

  • Marginal note:Practitioner of medicine

    (3) A practitioner of medicine who receives the controlled drug must immediately provide or deliver it

    • (a) for the purpose of its identification or analysis, to a person exempted under section 56 of the Act with respect to the possession of that drug for that purpose; or

    • (b) to the Minister.

  • SOR/2019-171, s. 20

Marginal note:Advertising

 It is prohibited to

  • (a) advertise a controlled drug to the general public; or

  • (b) publish any written advertisement respecting a controlled drug unless that advertisement displays the following symbol in a clear and conspicuous colour and size in the upper left quarter of its first page:

    The symbol consists of a diamond shape outline in which an uppercase letter C is centred.

    • SOR/2019-171, s. 20

Marginal note:Record keeping — specific cases

 Every person who is exempted under section 56 of the Act with respect to the possession or administration of a controlled drug and every practitioner of medicine who has received a controlled drug under subsection G.06.003(1) or (2) and every agent or mandatary of a practitioner of medicine who has received a controlled drug under subsection G.06.003(1) must

  • (a) keep a record of the following information for a two-year period beginning on the day on which the record is made:

    • (i) the name and quantity of any controlled drug purchased or received by them and the date on which it was purchased or received,

    • (ii) the name and address of the person from whom the controlled drug was purchased or received, and

    • (iii) details of the use of the controlled drug;

  • (b) provide any information respecting those controlled drugs that the Minister may require; and

  • (c) permit access to the records required to be kept by this Part.

  • SOR/2019-171, s. 20

Marginal note:Communication of information by Minister to nursing statutory body

  •  (1) The Minister may provide to a nursing statutory body any information concerning any member of that body that has been obtained under this Part, the Act or the Food and Drugs Act.

  • Marginal note:Non-application

    (2) Subsection (1) does not apply to a nurse practitioner.

  • Marginal note:Definitions

    (3) The following definitions apply in this section.

    member

    member means any person who is authorized by a nursing statutory body to practice nursing. (membre)

    nursing statutory body

    nursing statutory body means any provincial professional licensing authority that, in accordance with the laws of that province, authorizes a person to practise nursing. (organisme régissant la profession d’infirmier)

  • SOR/2019-171, s. 20

Marginal note:Notification of application for order of restoration

  •  (1) For the purpose of subsection 24(1) of the Act, notification of an application for an order of restoration must be given in writing to the Attorney General by registered mail and be mailed not less than 15 days before the date on which the application is to be made to a justice.

  • Marginal note:Content of notification

    (2) The notification must specify

    • (a) the name of the justice to whom the application is to be made;

    • (b) the time and place at which the application is to be heard;

    • (c) details concerning the controlled drug or other thing in respect of which the application is to be made; and

    • (d) the evidence on which the applicant intends to rely to establish that they are entitled to possession of the controlled drug or other thing referred to in paragraph (c).

  • SOR/2019-171, s. 20

 [Repealed, SOR/2019-171, s. 20]

 [Repealed, SOR/2019-171, s. 20]

 
Date modified: